Clinical Trials

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04127318 2022-09-23

Low-moderate Intensity Pedaling During Immunotherapy Administration

DermatologicGenitourinary

Urinary Bladder Neoplasms, Kidney Neoplasms, Motor Activity, Skin Neoplasms, Sarcopenia

NCT05395260 2022-08-19

FL- 101 Study in Non-Metastatic MIBC

Phase EARLY_PHASE1 Withdrawn

Urinary Bladder Neoplasms

NCT04972253 2022-08-10

(BLASST)-3

Acrocephalosyndactylia, Urinary Bladder Neoplasms

NCT03839472 2022-05-11

Continuous Bladder Irrigation Following Transurethral Resection of Bladder Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04464967 2021-05-12

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Phase 1/2 Withdrawn

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Recurrence, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04109092 2020-12-14

A Study of Stimulator of Interferon Genes (STING) Agonist E7766 in Non-muscle Invasive Bladder Cancer (NMIBC) Including Participants Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy, INPUT-102

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT04073160 2020-07-07

TRIO Bladder

Urinary Bladder Neoplasms

NCT03517995 2020-05-28

Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04089163 2020-03-30

A Study of Toca 511 & Toca FC in Patients With Recurrent High Grade Non-Muscle Invasive Bladder Cancer (Toca 8)

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT04040725 2019-12-17

Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer With FGFR1/2 Overexpression

Urinary Bladder Neoplasms

NCT00880854 2019-11-15

Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer

Urinary Bladder Neoplasms

NCT03298958 2019-06-12

Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

Urinary Bladder Neoplasms

NCT02438852 2019-04-16

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

Urinary Bladder Neoplasms, Pain, Postoperative

NCT02471495 2018-05-07

RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT01710293 2018-02-26

PACT CREATE 3

BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Colorectal Neoplasms

NCT02845050 2018-02-13

JaNEO

Phase 1/2 Withdrawn

Urinary Bladder Neoplasms

NCT01826097 2018-02-01

Improving Sensitivity of Urine Cytology for Bladder Cancer

Urinary Bladder Neoplasms

NCT03150836 2017-10-19

Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer

Urinary Bladder Neoplasms

NCT03007771 2017-10-06

Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia

GastrointestinalGenitourinaryGynecologicSarcoma

Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Pelvic Neoplasms, Rectal Neoplasms, Sarcoma

NCT02252393 2016-11-09

Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer

Urinary Bladder Neoplasms

NCT00041171 2016-07-12

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

BreastCNSGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT01799499 2015-09-01

NMIBC TURBT HG

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT00785694 2015-04-24

Recurrence of Bladder Cancer After Transurethral Resection With Hexvix

Phase 4 Withdrawn

Urinary Bladder Neoplasms

NCT02254915 2015-04-01

SHTC-EUROPE-1

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Neoplasms, Neoplasms by Site, Urogenital Neoplasms, Urologic Diseases, Urologic Neoplasms

NCT01284205 2014-08-29

First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01688414 2014-07-29

Imaging During Surgery in Diagnosing Patients With Prostate, Bladder, or Kidney Cancer

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT01907308 2014-04-29

Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01639521 2014-01-29

Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer

Urinary Bladder Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

NCT00014287 2013-12-19

Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer

Urinary Bladder Neoplasms

NCT00084578 2013-07-15

Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder

Urinary Bladder Neoplasms

NCT01700010 2013-01-17

Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

Urinary Bladder Neoplasms, Neoplasms

NCT00824811 2012-08-02

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel